Skip to main content
Caplight Logo









MEACOR

MEACOR

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://meacor.com/

Last Round

Series A

May 14, 2024

Total Funding Raised

$15.9M

Company Overview

MEACOR is a healthtech company that develops a catheter-based medical device designed to repair the mitral and tricuspid valves.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicetranscatheter repairmitral valve repairtricuspid valve repairannuloplastyminimally invasive surgerycryoadhesioncatheter-based interventionstructural heartinterventional cardiologyvalve regurgitationmedtechcardiac surgeryclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MEACOR Comparables

Compare MEACOR with similar companies based on industry and business-model similarity.

MEACOR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valcare Medical
89%
Micro Interventional Devices, Inc.
87%
MVRx, Inc.
85%

MEACOR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 14, 2024
AcceleratorJun 7, 2022
SeedJan 8, 2018
SeedJun 28, 2016

Key People

Founding team and executive leadership

Toufic Azar

Co-founder, CEO

Founding Team

MEACOR Investors

Notable investors and investment history

MEACOR investors
InvestorRounds
BerytechSeed
IM CapitalSeed, Series A
MedTech InnovatorAccelerator, Series A
IM FndngSeries A
Middle East Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 35% MoM.

  • May 14, 2024

    $15M round completed.

MEACOR Filings

Explore SEC and related filing metadata, where available.

MEACOR filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MEACOR's valuation, stock price, and market status.

Is MEACOR a public or private company?

MEACOR is a private company.

What is the current stock price of MEACOR?

MEACOR is a private company with no public stock price. No recent secondary market data is available.

How much is MEACOR worth (valuation)?

Valuation information for MEACOR is not publicly available.

Can I buy MEACOR stock?

MEACOR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MEACOR's last funding round?

MEACOR's most recent funding round was Series A on May 14, 2024.

Who are the main investors in MEACOR?

Key investors in MEACOR include Berytech, IM Capital, MedTech Innovator, IM Fndng, Middle East Venture Partners.

Will MEACOR IPO soon?

No public IPO plans have been announced for MEACOR.

How can I track MEACOR secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MEACOR's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range8
Year Founded2015
Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?